IDEXX Laboratories Inc

IDEXX Laboratories Inc(IDXX)の株式分析

$560.360

+13.505 (+2.41%)終値時点

Loading chart…
高値
566.545
始値
553.600
出来高加重平均価格
559.84
出来高
708.92K
時価総額
40.79B
安値
552.620
売買代金
396.88M
EV/EBITDA(TTM)
22.58

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and provides services primarily for the companion animal veterinary; livestock, poultry and dairy; and water testing industries. It also manufactures and sells human medical point-of-care diagnostic products. Its products and services include point-of-care veterinary diagnostic products, comprised of instruments, consumables, and rapid assay test kits. It also includes veterinary reference laboratory diagnostic and consulting services. It offers practice management systems, software and diagnostic imaging systems and services used by veterinarians. It also offers health monitoring, biological materials testing, laboratory diagnostic instruments, and services used by the biomedical research community. The Company provides diagnostic and health-monitoring products for livestock, poultry, and dairy; and products that test water for certain microbiological contaminants.

www.idexx.com

AI分析 of IDEXX Laboratories Inc (IDXX)

買い

IDEXX Laboratories Inc is a good buy right now due to its current price of $518, which is significantly lower than the average analyst price target of $670, indicating a potential upside of approximately 29%. Additionally, the company's forward P/E ratio of 31.45 suggests that it is trading at a reasonable valuation relative to its growth prospects, especially considering its recent earnings report that showed an EPS of 4.27, exceeding estimates by 8.10%.

アナリスト評価(10)

上値余地 +41.48%
買い
6 買い
3 中立
1 売り
現在: 560.36
安値
750.00
平均
792.78
高値
850.00

KeyBanc

2026-10-12

目標株価

—

Sector Weight

Barclays

2026-08-11

目標株価

$710

オーバーウェイト

Citi

2026-08-05

目標株価

$670

中立

UBS

2026-07-27

目標株価

$620

中立

Stifel

2026-07-15

目標株価

$564.42

買い

バリュエーション指標

IDEXX Laboratories Inc(IDXX)の現在の予想PERは31.45で、5年平均は45.95です。

予想PER

割安
5年平均 P/E
45.95
現在のP/E
31.45
割高
55.20
割安
36.70

予想EV/EBITDA

割安
5年平均 EV/EBITDA
32.01
現在のEV/EBITDA
22.58
割高
38.12
割安
25.90

予想PSR

割安
5年平均 P/S
10.31
現在のP/S
8.40
割高
12.13
割安
8.48

Alphio AI による IDXX の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%IDXX

$650.45

シナリオ価格

基

基本

基本 · 50%IDXX

$608.98

シナリオ価格

弱

弱気

弱気 · 25%IDXX

$597.63

シナリオ価格

IDXX を保有するクジラ

L

Loring, Wolcott & Coolidge Fiduciary Advisors, LLP

+ を保有IDXX

+7.34%

3か月リターン

W

Walter Scott & Partners Limited

+ を保有IDXX

+6.20%

3か月リターン

C

Curi Capital, LLC

+ を保有IDXX

+5.77%

3か月リターン

J

Joel R. Mogy Investment Counsel Inc.

+ を保有IDXX

+5.71%

3か月リターン

C

Chilton Investment Company, Inc.

+ を保有IDXX

+5.63%

3か月リターン

W

William Blair Investment Management, LLC

+ を保有IDXX

+5.42%

3か月リターン

イベントタイムライン

2026-09-16 (ET)

07:30:00

IDEXX Laboratories Acquires CoVetAI to Expand Software Ecosystem

2026-08-11 (ET)

07:30:00

IDEXX Launches Catalyst proBNP Test, Enhancing Cardiac Testing Capabilities

2026-08-04 (ET)

09:00:00

IDEXX Laboratories Q2 Revenue $1.22B Beats Expectations

08:30:00

Idexx Reports Q2 EPS of $4.27, Beating Consensus of $3.93

07:00:00

IDEXX Laboratories Reports Q2 Revenue of $1.22B

ニュース

IDXX のよくある質問 — Alphio AI が回答

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and provides services primarily for the companion animal veterinary; livestock, poultry and dairy; and water testing industries. It also manufactures and sells human medical point-of-care diagnostic products. Its products and services include point-of-care veterinary diagnostic products, comprised of instruments, consumables, and rapid assay test kits. It also includes veterinary reference laboratory diagnostic and consulting services. It offers practice management systems, software and diagnostic imaging systems and services used by veterinarians. It also offers health monitoring, biological materials testing, laboratory diagnostic instruments, and services used by the biomedical research community. The Company provides diagnostic and health-monitoring products for livestock, poultry, and dairy; and products that test water for certain microbiological contaminants. It operates in the Healthcare sector (IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry).

IDEXX Laboratories Inc is a good buy right now due to its current price of $518, which is significantly lower than the average analyst price target of $670, indicating a potential upside of approximately 29%. Additionally, the company's forward P/E ratio of 31.45 suggests that it is trading at a reasonable valuation relative to its growth prospects, especially considering its recent earnings report that showed an EPS of 4.27, exceeding estimates by 8.10%.

10 analysts cover IDXX: 6 rate it Buy, 3 Hold and 1 Sell. The average price target is 792.78.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める